AP3196A - New process for obtaining the crystalline form V of agomelatine - Google Patents

New process for obtaining the crystalline form V of agomelatine

Info

Publication number
AP3196A
AP3196A AP2009004936A AP2009004936A AP3196A AP 3196 A AP3196 A AP 3196A AP 2009004936 A AP2009004936 A AP 2009004936A AP 2009004936 A AP2009004936 A AP 2009004936A AP 3196 A AP3196 A AP 3196A
Authority
AP
ARIPO
Prior art keywords
agomelatine
obtaining
crystalline form
new process
new
Prior art date
Application number
AP2009004936A
Other languages
English (en)
Other versions
AP2009004936A0 (en
Inventor
Jean-Claude Pascal
Linol Julie
Coquerel Gerard
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40418877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP3196(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of AP2009004936A0 publication Critical patent/AP2009004936A0/xx
Application granted granted Critical
Publication of AP3196A publication Critical patent/AP3196A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C07C231/24—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/08—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Battery Electrode And Active Subsutance (AREA)
  • Manufacture Of Metal Powder And Suspensions Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
AP2009004936A 2008-08-05 2009-07-27 New process for obtaining the crystalline form V of agomelatine AP3196A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0804466A FR2934856B1 (fr) 2008-08-05 2008-08-05 Nouveau procede d'obtention de la forme cristalline v de l'agomelatine

Publications (2)

Publication Number Publication Date
AP2009004936A0 AP2009004936A0 (en) 2009-08-31
AP3196A true AP3196A (en) 2015-03-31

Family

ID=40418877

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2009004936A AP3196A (en) 2008-08-05 2009-07-27 New process for obtaining the crystalline form V of agomelatine

Country Status (46)

Country Link
US (1) US8252957B2 (ar)
EP (1) EP2151430B1 (ar)
JP (1) JP5047240B2 (ar)
KR (1) KR101118335B1 (ar)
CN (1) CN101643432B (ar)
AP (1) AP3196A (ar)
AR (1) AR074889A1 (ar)
AT (1) ATE518825T1 (ar)
AU (1) AU2009203071B2 (ar)
BR (1) BRPI0903058A2 (ar)
CA (1) CA2674770C (ar)
CL (1) CL2009001685A1 (ar)
CO (1) CO6120151A1 (ar)
CR (1) CR10952A (ar)
CY (1) CY1111873T1 (ar)
DK (1) DK2151430T3 (ar)
EA (1) EA016896B1 (ar)
EC (1) ECSP099554A (ar)
ES (1) ES2371047T3 (ar)
FR (1) FR2934856B1 (ar)
GE (1) GEP20125408B (ar)
GT (1) GT200900215A (ar)
HK (1) HK1141005A1 (ar)
HN (1) HN2009001437A (ar)
HR (1) HRP20110712T1 (ar)
IL (1) IL200126A (ar)
JO (1) JO2812B1 (ar)
MA (1) MA31223B1 (ar)
ME (1) ME00929B (ar)
MX (1) MX2009008046A (ar)
MY (1) MY151042A (ar)
NI (1) NI200900154A (ar)
NZ (1) NZ578826A (ar)
PE (1) PE20100153A1 (ar)
PL (1) PL2151430T3 (ar)
PT (1) PT2151430E (ar)
RS (1) RS52002B (ar)
SA (1) SA109300499B1 (ar)
SG (1) SG158830A1 (ar)
SI (1) SI2151430T1 (ar)
SV (1) SV2009003345A (ar)
TW (1) TW201008901A (ar)
UA (1) UA102816C2 (ar)
UY (1) UY32014A (ar)
WO (1) WO2010015747A1 (ar)
ZA (1) ZA200905334B (ar)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101781226B (zh) 2009-12-23 2012-03-28 天津泰普药品科技发展有限公司 阿戈美拉汀及其药物组合物
WO2012093402A1 (en) * 2011-01-04 2012-07-12 Symed Labs Limited Processes for the preparation of n-[2-(7-methoxy-1-naphthyl)ethyl]acetamide
WO2012130837A1 (en) 2011-03-28 2012-10-04 Ratiopharm Gmbh Solid agomelatine in non-crystalline form
EP2872129B1 (en) 2012-07-16 2017-03-08 ratiopharm GmbH Complex of agomelatine and cyclodextrin
WO2015124496A1 (en) 2014-02-19 2015-08-27 Synthon B.V. Pharmaceutical composition comprising amorphous agomelatine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1703641A1 (ru) * 1988-02-23 1992-01-07 Ростовский государственный университет Способ получени 3,5-ди-трет.бутил-4-оксиацетанилида
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
YU48420B (sh) * 1991-03-25 1998-07-10 Hoechst Aktiengesellschaft Postupak za dobijanje biološki razgradljivih mikročestica sa dugotrajnim delovanjem
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
FR2889522B1 (fr) * 2005-08-03 2007-12-28 Servier Lab Nouvelle forme cristalline iv de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2889521B1 (fr) * 2005-08-03 2007-12-28 Servier Lab Nouvelle forme cristalline iii de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2889523B1 (fr) * 2005-08-03 2007-12-28 Servier Lab Nouvelle forme cristalline v de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
US20080280991A1 (en) * 2007-05-08 2008-11-13 Auspex Pharmaceuticals, Inc. Substituted naphthalenes
FR2923482B1 (fr) * 2007-11-09 2010-01-29 Servier Lab Nouvelle forme cristalline vi de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
KR20100017070A (ko) 2010-02-16
CY1111873T1 (el) 2015-11-04
IL200126A0 (en) 2010-05-31
JO2812B1 (ar) 2014-09-15
SV2009003345A (es) 2010-02-01
FR2934856A1 (fr) 2010-02-12
CN101643432B (zh) 2012-12-12
EP2151430B1 (fr) 2011-08-03
PT2151430E (pt) 2011-08-25
AU2009203071A1 (en) 2010-02-25
BRPI0903058A2 (pt) 2010-05-25
MY151042A (en) 2014-03-31
RS52002B (en) 2012-04-30
IL200126A (en) 2013-04-30
SA109300499B1 (ar) 2013-10-06
HK1141005A1 (en) 2010-10-29
NZ578826A (en) 2010-11-26
ECSP099554A (es) 2010-03-31
CA2674770A1 (fr) 2010-02-05
AP2009004936A0 (en) 2009-08-31
UY32014A (es) 2010-01-29
EP2151430A1 (fr) 2010-02-10
EA200900944A1 (ru) 2010-04-30
GT200900215A (es) 2011-07-19
DK2151430T3 (da) 2011-11-21
NI200900154A (es) 2010-03-25
CL2009001685A1 (es) 2010-07-19
KR101118335B1 (ko) 2012-03-09
SI2151430T1 (sl) 2011-10-28
PE20100153A1 (es) 2010-03-06
JP2010037345A (ja) 2010-02-18
HRP20110712T1 (hr) 2011-11-30
CA2674770C (fr) 2012-04-17
CN101643432A (zh) 2010-02-10
AU2009203071B2 (en) 2013-10-31
US20100036165A1 (en) 2010-02-11
GEP20125408B (en) 2012-02-27
EA016896B1 (ru) 2012-08-30
WO2010015747A1 (fr) 2010-02-11
CO6120151A1 (es) 2010-01-29
SG158830A1 (en) 2010-02-26
TW201008901A (en) 2010-03-01
UA102816C2 (ru) 2013-08-27
AR074889A1 (es) 2011-02-23
JP5047240B2 (ja) 2012-10-10
FR2934856B1 (fr) 2010-08-13
HN2009001437A (es) 2011-09-22
CR10952A (es) 2009-10-15
ATE518825T1 (de) 2011-08-15
ES2371047T3 (es) 2011-12-26
PL2151430T3 (pl) 2011-12-30
MA31223B1 (ar) 2010-03-01
US8252957B2 (en) 2012-08-28
MX2009008046A (es) 2010-03-23
ME00929B (me) 2012-06-20
ZA200905334B (en) 2010-05-26

Similar Documents

Publication Publication Date Title
HK1141006A1 (en) New process for the synthesis of agomelatine
EP2212248A4 (en) PROCESS FOR THE PREPARATION OF GRAPHS
HK1141013A1 (en) Process for the preparation of certain substituted sulfilimines
AP3167A (en) New process for the synthesis of agomelatine
IL208792A0 (en) Process for the preparation of amides
ZA200907191B (en) Process for the preparation of gefitiib
SI2189442T1 (sl) Postopek in intermediati za pripravo aliskirena
EP2344468A4 (en) PROCESS FOR PREPARING RAMELTÉON
HK1141004A1 (en) New process for the synthesis of agomelatine
HK1141005A1 (en) New process for obtaining the crystalline form v of agomelatine
IL243809A (en) Process for the production of γ-ketosulfide compounds and γ-ketosulfide compounds obtained
EG26332A (ar) عمليه لتحضير بنزونوبرونينات
HU0700818D0 (en) Process for the preparation of polyirocyanates of the diphenylmethone series
IL217139A0 (en) Process for the preparation of arylpyridinyl compounds
IL208868A0 (en) Processes for the preparation of amides
IL215022A0 (en) Novel process for the preparation of enaminocarbonyl compounds
IL211382A0 (en) Process for the preparation of ethanedinitrile
IL217460A0 (en) Novel process for the preparation of 4-aminobut-2-enolides
GB0905895D0 (en) Process for the preparation of chalcogenone compounds
GB0812613D0 (en) Process for the preparation of 1-deoxyidonojirimycin
PL388950A1 (pl) Sposób wytwarzania polikaprolaktonu